Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05339412 · ClinicalTrials.gov registry record · NA

Technology-based Training Tool for PHAT Life

A NA study of HIV Infection and Sexually Transmitted Infections, sponsored by Oregon Research Behavioral Intervention Strategies.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05339412 is a NA study of HIV Infection and Sexually Transmitted Infections that has completed, run by Oregon Research Behavioral Intervention Strategies. The registered enrollment target is 24 participants, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05339412, a NA study of HIV Infection and Sexually Transmitted Infections, has completed, sponsored by Oregon Research Behavioral Intervention Strategies.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Youth under age 18 involved in the criminal justice system are disproportionately minorities \& affected by substance abuse, mental illness, \& HIV/STI. Most young offenders are released on community supervision without the STI, mental health, or substance use screening, diagnosis, \& treatment afforded detained youth, despite similar rates of risk behavior. Their long-term trajectory is poor, costs to society are high, \& lasting effects on community well-being \& individual employment prospects are profound. Altering this trajectory is a public health priority. Preventing HIV Among Teens (PHAT) Life is an evidence-based program that meets the need in juvenile justice to address youths' co-morbid health problems. The next step in ensuring that this decade-long line of research produces actual, real-world improvements in the lives of probation youth is to develop a PHAT Life training strategy that is effective, cost-effective, \& sustainable within juvenile justice settings. The private/public collaboration between ORBIS \& UIC will leverage existing resources \& competencies to create a commercially viable technology-based training tool for PHAT Life with great potential for sustainability \& cost-effectiveness. This Phase II uses a formative process to refine, enhance \& complete the technology-based training tool to include: (a) an interactive multimedia web browser \& mobile application, (b) dynamic multimedia presentations \& interactive queries, (c) video examples of mock intervention delivery, (d) audio narration along with scripted language, (e) brief quizzes to ensure comprehension \& knowledge acquisition, (f) opportunities to "learn more" by clicking on tabs for supplemental information, (g) targeted referrals to appendix materials, (h) games to promote engagement, \& (i) other adaptations based on Phase I feedback. The proposed technology-based training tool should be highly sustainable, because it (a) relies on "indigenous" personnel to deliver the inte

Interventions

  • BEHAVIORAL Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life

Study Locations (1)

Oregon

  • Oregon Research Behavioral Intervention Strategies, Inc. - Springfield

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-01-26
Est. Completion 2024-12-20
Phase NA

What the Registry Record Tells You About NCT05339412

The ClinicalTrials.gov registry entry for NCT05339412 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (90% lower). The listed sponsor is Oregon Research Behavioral Intervention Strategies, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infection appearing as the primary indexed condition, and to 1 intervention - of which Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life is the first listed.

NCT05339412 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT05339412 about?

NCT05339412 is a clinical study titled "Technology-based Training Tool for PHAT Life". Youth under age 18 involved in the criminal justice system are disproportionately minorities \& affected by substance abuse, mental illness, \& HIV/STI. Most young offenders are released on community supervision without the STI, mental health, or substance use screening, diagnosis, \& treatment affo...

What is the current status of trial NCT05339412?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2024-01-26. Estimated completion is 2024-12-20.

What conditions does trial NCT05339412 study?

This clinical trial studies the following conditions: HIV Infection, Sexually Transmitted Infections, Implementation.

What interventions are being tested in trial NCT05339412?

The interventions under investigation include: Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life (BEHAVIORAL).

Who is sponsoring clinical trial NCT05339412?

This trial is sponsored by Oregon Research Behavioral Intervention Strategies, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05339412 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.